Oxbryta Medication Recall for Sickle Cell Disease
In September 2024, Pfizer Inc. published a press release announcing it voluntarily recalled all Oxbryta (Voxelotor). Oxbryta was used to treat sickle cell disease and was once thought of as a breakthrough treatment for the deadly disorder. The following day, the United States Food & Drug Administration (FDA) published a safety alert regarding Pfizer’s recall....
CONTINUE READING